Vaccination against meningitis B: is it worth it?

Abstract

Summary: when a new vaccine is licensed having passed the tests for efficacy and safety, governments who have to pay for it to be used, as in the UK, will carry out a careful economic appraisal before making it generally available. In this challenging article, Dr Peter English discusses whether or not a new vaccine for meningitis that has just been licensed and that could save lives is actually worth it.

Keywords

• health protection
• meningitis B
• meningococcal disease
• meningococcal group-C conjugate vaccine